A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

April 22, 2021

Study Completion Date

June 10, 2021

Conditions
Non-alcoholic Steatohepatitis
Interventions
DRUG

Semaglutide

Semaglutide given subcutaneously (s.c., under the skin) once-weekly for 48 weeks

DRUG

Placebo (semaglutide)

Semaglutide placebo s.c. given once-weekly for 48 weeks

Trial Locations (38)

21202

Mercy Medical Center, GI Research, Baltimore

23298

VCU Health Systems, Richmond

27710

Duke University, Durham

30060

Gastrointestinal Specialists of Georgia, Marietta

30309

Piedmont Research Institute, Atlanta

32610

University of Florida-CTRB, Gainesville

33136

University of Miami/Schiff Center for Liver Diseases, Miami

33434

Excel Medical Center Clinical Trials, LLC, Boca Raton

37076

Digestive Health Research - Tristar Summit Medical Center, Hermitage

37211

Quality Medical Research, Nashville

38138

Gastroenterology Center For The Mid-South, Germantown

40508

University of Kentucky Hospital, Lexington

41013

Hospital Virgen del Rocío, Seville

46202

Indiana University, Indianapolis

46635

Digestive Research Alliance of Michiana, South Bend

48202

Henry Ford Hospital, Detroit

55131

Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, Mainz

60590

Hepatologie Universitätsklinikum Frankfurt/M, Frankfurt

69200

Groupe Hospitalier Mutualiste des Portes du Sud, Vénissieux

69317

Hôpital de la Croix Rousse, Lyon

75014

Hôpital Cochin, Paris

75651

Groupe Hospitalier PITIE-SALPETRIERE, Paris

76012

Texas Clinical Research Institute, LLC, Arlington

78215

American Research Corporation at the Texas Liver Institute, San Antonio

85224

Arizona Liver Health, Chandler

85381

The Institute for Liver Health dba Arizona Liver Health, Peoria

92037

Altman Clinical Translational Research Institute, La Jolla

92110

Hôpital Beaujon, Clichy

92118

Southern California Research Center, Coronado

92377

Inland Empire Clinical Trials LLC, Rialto

02114

Massachusetts General Hospital, Boston

75390-8887

The University of Texas Southwestern Medical Center - Dallas, Dallas

04103

Universitätsklinikum Leipzig, Klinik und Poliklinik, Leipzig

08035

Hospital Vall d'Hebron, Barcelona

B15 2TH

New Queen Elizabeth Hospital Birmingham, Birmingham

SE5 9RS

Liver Research, London

NE7 7DN

Freeman Hospital, Newcastle, Newcastle upon Tyne

NG7 2UH

Nottingham University Hospital, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY